The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,107,000 project grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on tumor extravasation in zebrafish as a prognostic marker and therapeutic target for kidney cancer metastasis. The 3-year grant, which began on September 1, 2023 and runs through August 31, 2026, will support basic, applied, and advanced biomedical research with the goal of transforming healthcare for Service Members and the American public. No details were provided about any federal grant sub-awards associated with this project.
Generated 6/11/24, 5:03 AM